West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
398.29
+3.56 (0.90%)
At close: Oct 27, 2026, 4:00 PM EDT
396.02
-2.27 (-0.57%)
Pre-market: Oct 28, 2026, 7:39 AM EDT

WST Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, WST stock has a consensus rating of "Strong Buy" and an average price target of $416.4. The average 1-year stock price forecast is 4.55% higher than the current stock price, while the lowest is $340 (-14.64%) and the highest is $459 (+15.24%).

Price Target: $416.4 (+4.55%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$340$416.4$412$459
Change-14.64%+4.55%+3.44%+15.24%

Analyst Ratings

The average analyst rating for WST stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy101111111212
Buy223343
Hold312210
Sell010001
Strong Sell000000
Total151516161716

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Maintains
$410 → $420
BuyMaintains$410 → $420+5.45%Oct 13, 2026
Barclays
Barclays
Buy
Maintains
$400 → $440
BuyMaintains$400 → $440+10.47%Oct 7, 2026
Morgan Stanley
Morgan Stanley
Buy
Upgrades
$365 → $400
BuyUpgrades$365 → $400+0.43%Sep 22, 2026
UBS
UBS
Buy
Maintains
$340 → $415
BuyMaintains$340 → $415+4.20%Sep 9, 2026
Citi
Citi
Buy
Maintains
$400 → $412
BuyMaintains$400 → $412+3.44%Aug 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.37B
from 3.07B
Increased by 9.78%
Revenue Next Year
3.59B
from 3.37B
Increased by 6.30%
EPS This Year
8.96
from 7.29
Increased by 22.91%
EPS Next Year
9.98
from 8.96
Increased by 11.43%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.83B2.89B2.95B2.89B3.07B3.37B
Revenue Growth
31.89%1.95%2.18%-1.92%6.25%9.78%
Gross Profit
1.18B1.14B1.13B998.50M1.10B1.27B
Gross Margin
41.59%39.36%38.31%34.51%35.91%37.59%
Operating Income
768.60M763.80M706.20M593.60M638.70M756.52M
Net Income
661.80M585.90M593.40M492.70M493.70M618.74M
EPS
----7.298.96
EPS Growth
----8.00%22.91%
Forward PE
53.5534.8442.2345.9036.6944.45
Dividend / Share
0.690.730.770.810.850.90
Dividend Growth
6.15%5.80%5.48%5.20%4.94%6.39%
Free Cash Flow
----468.90M430.60M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.4B
Avg3.4B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
10.7%
Avg
9.8%
Low
9.3%

EPS Forecast

EPS202620272028
High9.05
Avg8.96
Low8.83

EPS Growth

EPS Growth202620272028
High
24.1%
Avg
22.9%
Low
21.1%